Extremely high serum CA19-9 level along with elevated D-dimer in assisting detection of ruptured ovarian endometriosis

References

• Saunders PTK, Horne AW. Endometriosis: etiology, pathobiology, and therapeutic prospects. Cell. 2021;184(11):1444–2824.
   Web of Science ®Google Scholar
• Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397(10276):839–852.
   PubMed Web of Science ®Google Scholar
• Berveiller P, Ropert S, Mir O. Endometriosis. N Engl J Med. 2020;383(2):193–194.
   PubMed Web of Science ®Google Scholar
• Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997;24(2):235–258.
   PubMed Web of Science ®Google Scholar
• Meuleman C, Vandenabeele B, Fieuws S, et al. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2009;92(1):68–74.
   PubMed Web of Science ®Google Scholar
• Jenkins S, Olive DL, Haney AF. Endometriosis: pathogenetic implications of the anatomic distribution. Obstet Gynecol. 1986;67(3):335–338.
   PubMed Web of Science ®Google Scholar
• Gadducci A, Ferdeghini M, Prontera C, et al. The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis. Gynecol Oncol. 1992;44(2):147–154.
   PubMed Web of Science ®Google Scholar
• Gao Y, Wang J, Zhou Y, et al. Evaluation of serum CEA, CA19-9, CA72-4, CA125 and ferritin as diagnostic markers and factors of clinical parameters for colorectal cancer. Sci Rep. 2018;8(1):2732.
   PubMedGoogle Scholar
• Zhu J, Jiang L, Wen H, et al. Prognostic value of serum CA19-9 and perioperative CA-125 levels in ovarian clear cell carcinoma. Int J Gynecol Cancer. 2018;28:1108–1116.
   PubMedGoogle Scholar
• Lauby A, Colomban O, Corbaux P, et al. The increasing prognostic and predictive roles of the tumor primary chemosensitivity assessed by CA-125 elimination rate constant K (KELIM) in ovarian cancer: a narrative review. Cancers (Basel). 2021;14(1):98.
   PubMed Web of Science ®Google Scholar
• Zhang M, Cheng S, Jin Y, et al. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. Biochim Biophys Acta Rev Cancer. 2021;1875(2):188503.
   PubMed Web of Science ®Google Scholar
• Goff BA, Agnew K, Neradilek MB, et al. Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass. Gynecol Oncol. 2017;147(2):291–295.
   PubMed Web of Science ®Google Scholar
• Bean E, Naftalin J, Horne A, et al. Prevalence of deep and ovarian endometriosis in early pregnancy: ultrasound diagnostic study. Ultrasound Obstet Gynecol. 2022;59(1):107–113.
   PubMed Web of Science ®Google Scholar
• Hornstein MD, Harlow BL, Thomas PP, et al. Use of a new CA 125 assay in the diagnosis of endometriosis. Hum Reprod. 1995;10(4):932–934.
   PubMed Web of Science ®Google Scholar
• Harada T, Kubota T, Aso T. Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis. Fertil Steril. 2002;78(4):733–739.
   PubMed Web of Science ®Google Scholar
• Kurdoglu Z, Gursoy R, Kurdoglu M, et al. Comparison of the clinical value of CA 19-9 versus CA 125 for the diagnosis of endometriosis. Fertil Steril. 2009;92(5):1761–1763.
   PubMed Web of Science ®Google Scholar
• Yang H, Wang R, Zhao L, et al. Diagnosis and analysis of transabdominal and intracavitary ultrasound in gynecological acute abdomen. Comput Math Methods Med. 2021;2021:9508838.
   PubMed Web of Science ®Google Scholar
• Huang YH, Liou JD, Hsieh CL, et al. Long-term follow-up of patients surgically treated for ruptured ovarian endometriotic cysts. Taiwan J Obstet Gynecol. 2011;50(3):306–311.
   PubMed Web of Science ®Google Scholar
• Pratt JH, Shamblin WR. Spontaneous rupture of endometrial cysts of the ovary presenting as an acute abdominal emergency. Am J Obstet Gynecol. 1970;108(1):56–62.
   PubMed Web of Science ®Google Scholar
• Fujiwara H, Kosaka K, Hamanishi S, et al. Acute elevation of plasma D-dimer levels associated with rupture of an ovarian endometriotic cyst: case report. Hum Reprod. 2003;18(2):338–341.
   PubMed Web of Science ®Google Scholar
• Kurata H, Sasaki M, Kase H, et al. Elevated serum CA125 and CA19-9 due to the spontaneous rupture of ovarian endometrioma. Eur J Obstet Gynecol Reprod Biol. 2002;105(1):75–76.
   PubMed Web of Science ®Google Scholar
• Rani AK, Kapoor D. Ruptured ovarian endometrioma with an extreme rise in serum CA 125 level - a case report: ovarian endometrioma with very high CA-125 level. Gynecol Oncol Case Rep. 2012;2(3):100–101.
   PubMedGoogle Scholar
• Dai X, Jin C, Hu Y, et al. High CA-125 and CA19-9 levels in spontaneous ruptured ovarian endometriomas. Clin Chim Acta. 2015;450:362–365.
   PubMed Web of Science ®Google Scholar
• Göçmen A, Karaca M, Tarakçioğlu M. A ruptured ovarian endometrioma mimicking ovarian malignancy: case report. Eur J Gynaecol Oncol. 2003;24(5):445–446.
   PubMed Web of Science ®Google Scholar
• Schleedoorn MJ, Nelen WL, Dunselman GA, EndoKey Group, et al. Selection of key recommendations for the management of women with endometriosis by an international panel of patients and professionals. Hum Reprod. 2016;31(6):1208–1218.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Kobayashi Y, Dozono K, et al. Elevation of plasma D-dimer levels associated with rupture of ovarian endometriotic cysts. Taiwan J Obstet Gynecol. 2015;54(3):294–296.
   PubMed Web of Science ®Google Scholar
• Wang YQ, Xia WT, Wang F, et al. Use of cancer antigen 125, cancer antigen 19-9, and the neutrophil-to-lymphocyte ratio to diagnose mature cystic teratoma with torsion. Int J Gynecol Obstet. 2017;137(3):332–337.
   PubMed Web of Science ®Google Scholar
• He RH, Yao WM, Wu LY, et al. Highly elevated serum CA-125 levels in patients with non-malignant gynecological diseases. Arch Gynecol Obstet. 2011;283(S1):107–110.
   PubMedGoogle Scholar
• Yang H, Zhu L, Wang S, et al. Noninvasive diagnosis of moderate to severe endometriosis: the platelet-lymphocyte ratio cannot be a neoadjuvant biomarker for serum cancer antigen 125. J Minim Invasive Gynecol. 2015;22(3):373–377.
   PubMed Web of Science ®Google Scholar
• Anastasi E, Granato T, Falzarano R, et al. The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer. J Ovarian Res. 2013;6(1):44.
   PubMed Web of Science ®Google Scholar
• Somigliana E, Vigano P, Tirelli AS, et al. Use of the concomitant serum dosage of CA 125, CA 19-9 and interleukin-6 to detect the presence of endometriosis. Results from a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions. Hum Reprod. 2004;19(8):1871–1876.
   PubMed Web of Science ®Google Scholar
• Xavier P, Beires J, Belo L, et al. Are we employing the most effective CA 125 and CA 19-9 cut-off values to detect endometriosis? Eur J Obstet Gynecol Reprod Biol. 2005;123(2):254–255.
   PubMed Web of Science ®Google Scholar